title: Personalizing medicine for autoimmune and inflammatory diseases.
abstract: Therapies that target molecular pathways do not provide uniform benefits for all patients at present. New transformative therapies for autoimmune and inflammatory diseases require greater molecular understanding of patient subsets and the ability to personalize targeted therapies for each subset.
authors: Genentech, South San Francisco, California, USA. acc@gene.com
authors: Andrew C
authors: AC
authors: Chan
authors: Timothy W
authors: TW
authors: Behrens
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D018740:Genetic Heterogeneity; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use; D007249:Inflammation / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D057285:Precision Medicine
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents